The major findings of the present study were that treatment with the potent NF-κB inhibitor MEDS-23 significantly attenuated the elevated BT (fever) and decreased the severity of neurological deficits in post-ischemic stroke rats. The gene discussed is NFKB1; the disease is ischemic stroke.